Low aging scores
1 paper mentions it2 findings
Effects
2Tumor mutation burden
downin silico1
1 study
Tumor mutation burden
downin silico1
Low aging scores decrease tumor mutation burden in silico.
“patients with low aging scores (LAS group) exhibited better survival, lower tumor mutation burden (TMB)”
In silicocomparing LAS group to HAS group
Exploring the molecular and immune landscape of cellular senescence in lung adenocarcinoma
Frontiers in immunology
Survival
upin silico1
1 study
Survival
upin silico1
Low aging scores improve survival in silico.
“Notably, patients with low aging scores (LAS group) exhibited better survival”
In silicocomparing LAS group to HAS group
Exploring the molecular and immune landscape of cellular senescence in lung adenocarcinoma
Frontiers in immunology
Latest
Frontiers in Immunology
Exploring the molecular and immune landscape of cellular senescence in lung adenocarcinoma
Computational studyLung adenocarcinoma